Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 14Prostatic Neoplasms 7Breast Neoplasms 7Colorectal Neoplasms 6Hematologic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Myasthenia Gravis 3Melanoma 3Lung Neoplasms 3Leukemia 3Uterine Cervical Neoplasms 2Smoking 2Skin Neoplasms 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myeloid, Acute 2Hematologic Diseases 2Esophageal Neoplasms 2Disease 2Carcinoma, Renal Cell 2Carcinoma 2Brain Neoplasms 2Anemia 2Adenocarcinoma 2von Hippel-Lindau Disease 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Cytokine Release Syndrome × 30 days × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡